Clinical Trials Directory

Duloxetine for the Treatment of Dysthymia

The purpose of this study is to test the hypothesis that duloxetine (Cymbalta), in doses of 60 or 120 mg/day, is an effective and tolerable treatment for adult outpatients suffering from dysthymia. Dysthymia is chronic, mild depression characterized by feeling sad or low more days than not for more than 2 years.

Stanford is not currently accepting new patients for this trial. You may want to check clinicaltrials.gov to see if other locations are recruiting.

Investigator(s):

Intervention(s):

  • drug : duloxetine

Phase: N/A

Eligibility

Ages Eligible For Study:

18 Years - N/A

Inclusion Criteria

: - Sign an informed consent form - 18 years of age or older - Females not pregnant or breastfeeding or planning pregnancy and using an acceptable form of contraception - Meet DSM-IV criteria for dysthymia - A screening IDS-C score of 17 or greater - No history of serious or unstable medical disorder - Not taking any significant concurrent medications - Not currently receiving psychotherapy

External Links

Contact information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Nona Gamel
6507255180
Not Recruiting

Footer Links: